Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells.
Nakamura
T
T
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Japan.
Kokuryo
T
T
Okuda
M
M
Hashimoto
Y
Y
Inui
K
K
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D000970:Antineoplastic Agents / Q000633:toxicity; D002945:Cisplatin / Q000633:toxicity; D004249:DNA Damage; D053938:DNA Fragmentation / Q000187:drug effects*; D003982:Dibekacin / Q000031:analogs & derivatives* / Q000633:toxicity; D007684:Kidney Tubules / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D018374:LLC-PK1 Cells; D009336:Necrosis; D013552:Swine; D014640:Vancomycin / Q000633:toxicity*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003982:Dibekacin; D014640:Vancomycin; D007770:L-Lactate Dehydrogenase; C031986:arbekacin; D002945:Cisplatin